Drug factory · FDA FEI 3004908885

SGS Institut Fresenius GmbH

Tegeler Weg 33, Berlin, Germany

Germany: 1

No problems found at FDA's last inspection, Nov 23, 2023.

No Action Indicated: inspectors found no objectionable conditions.

6 drug inspections on record since 2010: 4 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
DeferoxamineTests it Mitem Pharma 87081-467
Ferric FerrocyanideTests it Heyl Chem.-pharm. Fabrik GmbH & Co. KG 58060-002
SelexipagTests it Actelion Pharmaceuticals US, Inc. 66215-602, 66215-604, 66215-606 +8

FDA inspection history

EndedResultProgramProblems noted
Nov 23, 2023No problems foundDrug Quality Assurance—
Jun 17, 2019No problems foundDrug Quality Assurance—
Jan 27, 2017No problems foundDrug Quality Assurance—
May 9, 2014No problems foundDrug Quality Assurance—
Apr 27, 2012Problems found, fixed voluntarilyDrug Quality Assurance—
Oct 19, 2010Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: analysis.